Issam BEN SAHRA

Issam BEN SAHRA

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2016 in Science
Verified
Journal Article
Closed access
PDF file
ISIssam BEN SAHRA
Issam BEN SAHRA
GHGerta Hoxhaj
Gerta Hoxhaj
SRStéphane J. H. Ricoult
Stéphane J. H. Ricoult
JAJohn M. Asara
John M. Asara
BMBrendan D. Manning
Brendan D. Manning
Controlling supplies for DNA and RNA synthesis: The mTORC1 protein kinase complex regulates anabolic metabolism and coordinates cellular signals that promote growth with availability of required precursor metabolites. Signaling through mTORC1 controls pyrimidine synthesis. Ben-Sahra et al. found that mTORC1 also functions by a different mechanism to regulate purine biosynthesis, thus generating precursors for the synthesis of RNA and DNA (see the Perspective by Ma and Jones). Signaling by mTORC1 caused accumulation of the transcription factor ATF4, which enhances production of the enzyme methylenetetrahydrofolate dehydrogenase 2, thus leading to increased production of the purine nucleotides needed for cell growth. Science , this issue p. 728 ; see also p. 670

15 March 2013 in Science
Verified
Journal Article
Closed access
PDF file
ISIssam BEN SAHRA
Issam BEN SAHRA
JHJessica J. Howell
Jessica J. Howell
JAJohn M. Asara
John M. Asara
BMBrendan D. Manning
Brendan D. Manning
Coordinating Metabolism: Growth factors help to coordinate metabolism with growth in part by stimulating the activity of the protein kinase mTORC1 (mechanistic target of rapamycin complex 1). Ben-Sahra et al. (p. 1323 , published online 21 February) and Robitaille et al. (p. 1320 , published online 21 February) independently identified a key target of mTORC1—carbamolyl-phosphate synthase 2, or CAD, the rate-limiting enzyme for de novo synthesis of pyrimidines. Metabolomic profiling and phosphoproteomic analyses of normal cells and cells lacking signaling by mTORC1 converged on CAD as a key point at which growth-promoting signals also ramp up production of nucleic acids.

1 April 2017 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
ISIssam BEN SAHRA
Issam BEN SAHRA
BMBrendan D Manning
Brendan D Manning

16 November 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
ACAnthony J. Covarrubias
Anthony J. Covarrubias
AKAbhijit Kale
Abhijit Kale
Rosalba PerroneRosalba Perrone
Rosalba Perrone
JLJose Alberto Lopez-Dominguez
Jose Alberto Lopez-Dominguez
APAngela Oliveira Pisco
Angela Oliveira Pisco
EVEric Verdin
Eric Verdin

17 May 2019 in Cancers
Verified
Journal Article
Open access
PDF file
EVElodie Villa
Elodie Villa
Eunus S. AliEunus S. Ali
Eunus S. Ali
USUmakant Sahu
Umakant Sahu
ISIssam BEN SAHRA
Issam BEN SAHRA
Cancer cells exhibit a dynamic metabolic landscape and require a sufficient supply of nucleotides and other macromolecules to grow and proliferate. To meet the metabolic requirements for cell growth, cancer cells must stimulate de novo nucleotide synthesis to obtain adequate nucleotide pools to support nucleic acid and protein synthesis along with energy preservation, signaling activity, glycosylation mechanisms, and cytoskeletal function. Both oncogenes and tumor suppressors have recently been identified as key molecular determinants for de novo nucleotide synthesis that contribute to the maintenance of homeostasis and the proliferation of cancer cells. Inactivation of tumor suppressors such as TP53 and LKB1 and hyperactivation of the mTOR pathway and of oncogenes such as MYC, RAS, and AKT have been shown to fuel nucleotide synthesis in tumor cells. The molecular mechanisms by which these signaling hubs influence metabolism, especially the metabolic pathways for nucleotide synthesis, continue to emerge. Here, we focus on the current understanding of the molecular mechanisms by which oncogenes and tumor suppressors modulate nucleotide synthesis in cancer cells and, based on these insights, discuss potential strategies to target cancer cell proliferation.

22 March 2021 in Molecular Cell
Verified
Journal Article
Closed access
EVElodie Villa
Elodie Villa
USUmakant Sahu
Umakant Sahu
BOBrendan P. O’hAra
Brendan P. O’hAra
Eunus S. AliEunus S. Ali
Eunus S. Ali
KHKathryn A. Helmin
Kathryn A. Helmin
ISIssam BEN SAHRA
Issam BEN SAHRA